KOLMAR BNH Co.,Ltd. (KOSDAQ:200130)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,290
-470 (-4.00%)
May 20, 2026, 3:30 PM KST
Market Cap319.45B -10.3%
Revenue (ttm)574.88B -6.6%
Net Income-22.67B
EPS-800.00
Shares Out28.29M
PE Ration/a
Forward PEn/a
Dividend300.00 (2.59%)
Ex-Dividend DateAug 28, 2025
Volume101,282
Average Volume101,793
Open11,760
Previous Close11,760
Day's Range11,160 - 11,840
52-Week Range10,850 - 20,300
Betan/a
RSI46.05
Earnings DateMay 21, 2026

About KOLMAR BNH

Kolmar BNH Co., Ltd. engages in the research and development of cosmetics, health functional foods, and functional ingredients in South Korea and internationally. It also provides vitamins and minerals, weight control, sports/nutrition, intestinal health, and other products, as well as products for men/women. The company was formerly known as Sun Bio Tech and changed its name to Kolmar BNH Co., Ltd. in 2013. The company was founded in 2004 and is based in Sejong, South Korea. Kolmar BNH Co., Ltd. is a subsidiary of Kolmar Korea Holdings Co., Lt... [Read more]

Founded 2004
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 200130
Full Company Profile

Financial Performance

Financial Statements

News

Kolmar BNH Revolutionizes ESG with HemoHIM, an Eco-friendly Health Supplement

SEOUL, South Korea — Kolmar BNH (KRX: 200130), a leading Korean health functional food Original Development Manufacturing (ODM) firm, is at the forefront of Environmental, Social, and Governance (ESG)...

1 year ago - Financial Post

HemoHim Manufacturer Kolmar BNH Receives NAI Classification from the US FDA

SEOUL, South Korea — ‘HemoHim,’ an immune-boosting health supplement from Kolmar BNH (KRX: 200130), has earned international recognition for its quality from both the U.S. Food and Drug Administration...

1 year ago - Financial Post